Tokyo, Sept. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058988) titled 'Database study on the association between serum calcium control status and incidence of renal dysfunction in patients with chronic hypoparathyroidism' on Sept. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Teijin Pharma Limited
Condition:
Condition - Hypoparathyroidism
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the association between renal dysfunction and serum calcium control, conventional therapies (active Vitamin D3 and calcium supplements), and other factors in patients with chronic hypoparathyroidism in actual clinical setting...